My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    1.

    Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

    Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW; GENDER study.

    Diabetes Care. 2005 Apr;28(4):873-7.PMID: 15793188 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.

    Canibus P, Faloia E, Piva T, Muçai A, Serenelli M, Perna GP, Boscaro M, Piva R.

    Metabolism. 2008 May;57(5):593-7.PMID: 18442619 [PubMed - indexed for MEDLINE]Related articles

    3.

    Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: A study in patients with and without the metabolic syndrome.

    Pons D, Monraats PS, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Jukema JW.

    Dis Markers. 2009;26(2):75-83.PMID: 19407362 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.

    Garot P, Lefèvre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR Jr.

    J Am Coll Cardiol. 2005 Aug 16;46(4):606-12.PMID: 16098423 [PubMed - indexed for MEDLINE]Related articles

    5.

    The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.

    Pons D, Monraats PS, de Maat MP, Pires NM, Quax PH, van Vlijmen BJ, Rosendaal FR, Zwinderman AH, Doevendans PA, Waltenberger J, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

    Thromb Haemost. 2007 Dec;98(6):1323-8.PMID: 18064331 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.

    Hoffmann R, Stellbrink E, Schröder J, Grawe A, Vogel G, Blindt R, Kelm M, Radke PW.

    Am J Cardiol. 2007 Nov 1;100(9):1347-52. Epub 2007 Aug 9.PMID: 17950788 [PubMed - indexed for MEDLINE]Related articles

    7.

    Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization.

    Jackson JD, Muhlestein JB, Bunch TJ, Bair TL, Horne BD, Madsen TE, Lappé JM, Anderson JL; Intermountain Heart Collaborative Study Group.

    Am Heart J. 2003 May;145(5):875-81.PMID: 12766747 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.

    Monraats PS, Rana JS, Nierman MC, Pires NM, Zwinderman AH, Kastelein JJ, Kuivenhoven JA, de Maat MP, Rittersma SZ, Schepers A, Doevendans PA, de Winter RJ, Tio RA, Frants RR, Quax PH, van der Laarse A, van der Wall EE, Jukema JW.

    J Am Coll Cardiol. 2005 Sep 20;46(6):1093-100.PMID: 16168296 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction.

    Celik T, Turhan H, Kursaklioglu H, Iyisoy A, Yuksel UC, Ozmen N, Isik E.

    Coron Artery Dis. 2006 May;17(4):339-43.PMID: 16707956 [PubMed - indexed for MEDLINE]Related articles

    10.

    Target vessel revascularization following percutaneous coronary intervention. A 10-year report from the Danish Percutaneous Transluminal Coronary Angioplasty Registry.

    Jensen LO, Thayssen P, Kassis E, Rasmussen K, Saunamäki K, Thuesen L; Danish Percutaneous Transluminal Coronary Angioplasty Registry.

    Scand Cardiovasc J. 2005 Apr;39(1-2):30-5.PMID: 16097411 [PubMed - indexed for MEDLINE]Related articles

    11.

    Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study.

    Akcakoyun M, Kargin R, Tanalp AC, Pala S, Ozveren O, Akcay M, Barutcu I, Kirma C.

    Coron Artery Dis. 2008 Aug;19(5):337-43.PMID: 18607171 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention.

    Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW.

    J Am Coll Cardiol. 2004 Jan 7;43(1):8-14.PMID: 14715174 [PubMed - indexed for MEDLINE]Related articles

    13.

    Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.

    Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr.

    J Am Coll Cardiol. 2005 Jan 18;45(2):198-203.PMID: 15653015 [PubMed - indexed for MEDLINE]Related articles

    14.

    -455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement.

    Monraats PS, Rana JS, Zwinderman AH, de Maat MP, Kastelein JP, Agema WR, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

    Thromb Haemost. 2005 Mar;93(3):564-9.PMID: 15735811 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation.

    Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, Montesanti R, Di Sciascio G.

    Circulation. 2005 Jan 4;111(1):70-5.PMID: 15630038 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.

    Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A.

    Circulation. 2008 Feb 19;117(7):923-30. Epub 2008 Feb 4.PMID: 18250265 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic.

    Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR Jr.

    J Am Coll Cardiol. 2007 Apr 17;49(15):1611-8. Epub 2007 Apr 2.PMID: 17433951 [PubMed - indexed for MEDLINE]Related articles

    18.

    Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.

    Singh M, Williams BA, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Cutlip DE, Holmes DR Jr.

    J Am Coll Cardiol. 2006 Jan 3;47(1):34-9.PMID: 16386661 [PubMed - indexed for MEDLINE]Related articles

    19.

    Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention.

    Cho L, Lewis BE, Steen LH, Leya FS.

    Cardiology. 2005;104(2):97-100. Epub 2005 Jul 11.PMID: 16020949 [PubMed - indexed for MEDLINE]Related articles

    20.

    Provisional stenting for multivessel PCI.

    Han B, Liu L, Aboud M, Nahir M, Hasin Y.

    Int J Cardiovasc Intervent. 2005;7(1):46-51.PMID: 16019615 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity